Serum microRNA-33 levels in pre-diabetic and diabetic patients
Beydolah Shahouzehi1, Mostafa Eghbalian2, Hossein Fallah3
1Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
Abstract:
Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia and abnormal insulin secretion. MicroRNAs are small, non-coding RNAs that are able to affect cell biological functions and act as biomarkers for some diseases such as DM. In current study, we measured serum miR-33 in three groups (n = 15) as follows; non-diabetic control, pre-diabetic, and DM patients. Real-time PCR method was used to quantify miR-33 expression. miR-33 expression was significantly increased in pre-diabetic subjects compared to other two groups (p < 0.001). FBS (p < 0.001), insulin (p < 0.001), HOMA-IR (p < 0.001), and TG (p = 0.026) were higher in diabetic subjects than the other two groups. In people that had high physical activity, the number of diabetic subjects were zero and most of them were in pre-diabetic group (p = 0.019). Serum miR-33 level significantly and positively correlated with pre-diabetic state (B = 2.67, p = 0.000), Sex (B = 1.03, p = 0.025), and FBS (B = 0.04, p = 0.036) and also miR-33 was significantly and negatively correlated with HOMA-IR (B = - 1.58, p = 0.04). These findings support the possible role of miR-33 to monitor pre-diabetes onset and progression. It needs to be evaluated in future studies with high number of participants to clarify its mechanism and diagnostic viability.
Insights
Serum miR-33 levels are elevated in pre-diabetic individuals, suggesting its potential role in monitoring pre-diabetes. Further research is needed to confirm its diagnostic viability.
Area of Science:
- Biochemistry
- Genetics
- Endocrinology
Background:
- Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia.
- MicroRNAs (miRNAs) are small non-coding RNAs with regulatory roles in cellular functions and disease biomarkers.
- Dysregulation of miRNAs is implicated in the pathogenesis of DM.
Purpose of the Study:
- To investigate the expression levels of miR-33 in non-diabetic, pre-diabetic, and diabetic individuals.
- To explore the correlation between serum miR-33 levels and metabolic parameters associated with diabetes.
- To assess the potential of miR-33 as a biomarker for pre-diabetes.
Main Methods:
- Serum samples were collected from three groups: non-diabetic controls, pre-diabetic individuals, and DM patients (n=15 per group).
- Quantitative real-time PCR was employed to measure serum miR-33 expression levels.
- Statistical analyses were performed to determine correlations between miR-33 and clinical/biochemical parameters.
Main Results:
- Serum miR-33 expression was significantly higher in the pre-diabetic group compared to non-diabetic and diabetic groups (p < 0.001).
- Diabetic subjects exhibited elevated fasting blood sugar (FBS), insulin levels, HOMA-IR, and triglycerides (TG).
- miR-33 positively correlated with pre-diabetic state, sex, and FBS, and negatively with HOMA-IR.
Conclusions:
- Elevated serum miR-33 levels are associated with the pre-diabetic state.
- miR-33 may serve as a potential biomarker for monitoring the onset and progression of pre-diabetes.
- Larger-scale studies are warranted to elucidate the precise mechanism and diagnostic utility of miR-33 in diabetes.
More Related Videos
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
MicroRNAs
MicroRNAs
Diabetes Mellitus: Type 2 and Gestational


